The Director of the BC Centre for Excellence in HIV/AIDS, Dr. Julio Montaner, recounts a defining moment in Vancouver’s efforts to combat a major health epidemic.
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025